Page last updated: 2024-08-23

1-deoxynojirimycin and Idiopathic Parkinson Disease

1-deoxynojirimycin has been researched along with Idiopathic Parkinson Disease in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bandaru, VVR; Dawson, TM; Dawson, VL; Karuppagounder, SS; Kim, D; Kim, S; Ko, HS; Kwon, SH; Lee, G; Lee, H; Lee, S; Mao, X; Pandey, A; Rhee, P; Umanah, GE; Yin, X; Yun, SP	1
Hughes, DA; Mehta, A; Thomas, AS	1
Baker, R; Ginsberg, L; Goodwin, S; Hughes, DA; Mehta, AB; Milligan, A; Richfield, L	1

Reviews

1 review(s) available for 1-deoxynojirimycin and Idiopathic Parkinson Disease

Article	Year
Gaucher disease: haematological presentations and complications. British journal of haematology, 2014, Volume: 165, Issue:4 Topics: 1-Deoxynojirimycin; Anemia; Combined Modality Therapy; Disease Management; Enzyme Replacement Therapy; Gaucher Disease; Genetic Predisposition to Disease; Glucosylceramidase; Glycosphingolipids; Hemorrhagic Disorders; Humans; Inflammation; Lewy Body Disease; Lysosomes; Macrophage Activation; Multiple Myeloma; Parkinson Disease; Splenectomy; Splenomegaly; Thrombocytopenia; Unfolded Protein Response	2014

Article

Year

Gaucher disease: haematological presentations and complications.

British journal of haematology, 2014, Volume: 165, Issue:4

Topics: 1-Deoxynojirimycin; Anemia; Combined Modality Therapy; Disease Management; Enzyme Replacement Therapy; Gaucher Disease; Genetic Predisposition to Disease; Glucosylceramidase; Glycosphingolipids; Hemorrhagic Disorders; Humans; Inflammation; Lewy Body Disease; Lysosomes; Macrophage Activation; Multiple Myeloma; Parkinson Disease; Splenectomy; Splenomegaly; Thrombocytopenia; Unfolded Protein Response

2014

Other Studies

2 other study(ies) available for 1-deoxynojirimycin and Idiopathic Parkinson Disease

Article	Year
GBA1 deficiency negatively affects physiological α-synuclein tetramers and related multimers. Proceedings of the National Academy of Sciences of the United States of America, 2018, 01-23, Volume: 115, Issue:4 Topics: 1-Deoxynojirimycin; alpha-Synuclein; Cell Line, Tumor; Dopaminergic Neurons; Glucosylceramidase; Glycosphingolipids; Humans; Parkinson Disease; Protein Multimerization	2018
Effective treatment of an elderly patient with Gaucher's disease and Parkinsonism: a case report of 24 months' oral substrate reduction therapy with miglustat. Parkinsonism & related disorders, 2007, Volume: 13, Issue:6 Topics: 1-Deoxynojirimycin; Administration, Oral; Aged; Enzyme Inhibitors; Follow-Up Studies; Gaucher Disease; Hexosaminidases; Humans; Male; Parkinson Disease; Peptidyl-Dipeptidase A	2007

Article

Year

GBA1 deficiency negatively affects physiological α-synuclein tetramers and related multimers.

Proceedings of the National Academy of Sciences of the United States of America, 2018, 01-23, Volume: 115, Issue:4

Topics: 1-Deoxynojirimycin; alpha-Synuclein; Cell Line, Tumor; Dopaminergic Neurons; Glucosylceramidase; Glycosphingolipids; Humans; Parkinson Disease; Protein Multimerization

2018

Effective treatment of an elderly patient with Gaucher's disease and Parkinsonism: a case report of 24 months' oral substrate reduction therapy with miglustat.

Parkinsonism & related disorders, 2007, Volume: 13, Issue:6

Topics: 1-Deoxynojirimycin; Administration, Oral; Aged; Enzyme Inhibitors; Follow-Up Studies; Gaucher Disease; Hexosaminidases; Humans; Male; Parkinson Disease; Peptidyl-Dipeptidase A

2007